Radford Samuel W, Carlsson Anthony M, Barrett Graham D
Eye Clinic, Sir Charles Gairdner Hospital, Nedlands, Australia.
J Cataract Refract Surg. 2007 Jan;33(1):88-93. doi: 10.1016/j.jcrs.2006.09.014.
To determine the relative incidence of unwanted light images with the AcrySof SN60-AT intraocular lens (IOL) (Alcon) and the Akreos Adapt (Bausch & Lomb) IOL.
The Eye Clinic, Sir Charles Gairdner Hospital, Nedlands, Australia.
In a prospective randomized study of 61 patients who had cataract surgery, the relative incidence of unwanted light images with 2 biconvex acrylic double square-edged IOLs, the SN60-AT and Akreos Adapt, was compared. Patients were followed at 1 week and for a minimum of 6 weeks. At both follow-ups, patients were asked to rate their experience of dysphotopic phenomenon according to a set of questionnaire criteria. The Mann-Whitney test was used to analyze the ordinal data.
All 61 patients were interviewed at both stages of follow-up. The mean follow-up was 8 weeks +/- 2 (SD). At 1 week, there was significantly more dysphotopsia (positive and negative) with the SN60-AT IOL (37.5%) than with the Akreos Adapt IOL (24.1%) (P = .042). Significantly more patients with the SN60-AT IOL reported negative dysphotopsia at 1 week only. At 8 weeks, the incidence of positive and negative dysphotopsia declined to 31.3% and 20.7% in the SN60-AT group and Akreos Adapt group, respectively, and there was no longer a statistically significant difference between the 2 groups.
More patients with the SN60-AT IOL than with the Akreos Adapt IOL reported dysphotopsia. One week postoperatively, the difference was significant. The difference was primarily a result of the higher incidence of negative dysphotopsia with the SN60-AT IOL. At 8 weeks, the incidence of all types of light phenomena was significantly lower in both groups.
确定AcrySof SN60-AT人工晶状体(IOL)(爱尔康公司)和Akreos Adapt人工晶状体(博士伦公司)出现有害光图像的相对发生率。
澳大利亚内德兰兹查尔斯·盖尔德纳爵士医院眼科诊所。
在一项对61例接受白内障手术患者的前瞻性随机研究中,比较了两种双凸丙烯酸双方形边缘人工晶状体SN60-AT和Akreos Adapt出现有害光图像的相对发生率。对患者进行为期1周的随访,并至少随访6周。在两次随访中,要求患者根据一组问卷标准对其遇到的暗光现象体验进行评分。采用曼-惠特尼检验分析有序数据。
在随访的两个阶段对所有61例患者进行了访谈。平均随访时间为8周±2(标准差)。在1周时,SN60-AT人工晶状体组出现的暗光幻觉(阳性和阴性)显著多于Akreos Adapt人工晶状体组(分别为37.5%和24.1%)(P = 0.042)。仅在1周时,SN60-AT人工晶状体组报告有阴性暗光幻觉的患者显著更多。在8周时,SN60-AT组和Akreos Adapt组阳性和阴性暗光幻觉的发生率分别降至31.3%和20.7%,两组之间不再存在统计学显著差异。
报告有暗光幻觉的SN60-AT人工晶状体植入患者多于Akreos Adapt人工晶状体植入患者。术后1周时,差异显著。这种差异主要是由于SN60-AT人工晶状体阴性暗光幻觉的发生率较高。在8周时,两组中所有类型光现象的发生率均显著降低。